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ABSTRACT 
Chemoprevention by naturally occurring agents is gaining much attention as a newer 
dimension in the management of cancer. Many naturally occurring agents have shown cancer 
chemopreventive potential in a variety of bioassay systems and animal models, having 
relevance to human disease. Phytic acid or Inositol hexaphosphate (IP6), an antioxidant, is a 
naturally occurring polyphosphorylated carbohydrate that has shown a strong anticancer 
activity in several experimental models. We assessed the protective effects of Phytic acid 
against the 7, 12-dimethylbenz [a] anthracene (DMBA)/ 12-O-tetradecanoylphorbol-13-
acetate (TPA) induced mouse skin tumorigenesis at 4 and 16 weeks, the time before and after 
the tumor development. At molecular level we studied expression and promoter CpG 
methylation status of p21, DAPK1 and COX-2. Our data suggests exposure of DMBA/TPA 
methylated the promoter region of p21 and DAPK1 genes in time dependent manner that 
could be the cause of down regulation of their expression with time, which were reversed by 
administration of phytic acid. But we did not observe methylation in COX-2 whereas 
upregulation of COX-2 was observed at protein level in mice treated with DMBA followed 
by TPA in time dependent manner.  Administration of phytic acid prevented theses 
DMBA/TPA induced molecular changes. Study provides a rationale for cancer 
chemoprevention by natural occurring compounds like Phytic acid. 
Introduction 
 
The term 'cancer' represents a range of different type of 
malignant diseases; all of them exhibit uncontrolled cell 
division, tissue invasion and spreading as common 
characteristics. Skin cancer contributes approximately 30% of 
all newly diagnosed cancer in the world and solar ultraviolet 
radiation is an established cause of approximately 90% of all 
skin cancers [1]. Nonmelanoma skin cancer (NMSC) is the 
most common form of human cancer, with incidence rates 
dramatically rising during the last decade, perhaps as a result 
of increased sun exposure and the continuous depletion of the 
ozone layer [2, 3]. It is widely accepted that squamous cell 
carcinomas (SCCs), which are responsible for the majority of 
NMSC-related deaths, result from the accumulation of genetic 
alterations [4]. 
Different types of animal models of cancer have been 
developed to understand the cellular and molecular alterations 
associated with the process of carcinogenesis. Chemically 
induced two-stage mouse skin carcinogenesis represents one 
of the well-established in vivo models for study the sequential 
and step wise development of tumors [5]. In this system, 
tumor initiation is accomplished through a single topical 
application of a carcinogen, typically 7, 12-dimethylbenz (a) 
anthracene (DMBA). Tumor promotion takes place when the 
initiated cells are expanded due to repeated applications of 12-
Otetradecanoylphorbol- 13-acetate (TPA), a hyper 
proliferative stimulus that promotes the generation of 
papillomas.  
Chemoprevention by natural compound is a novel approach 
against cancer. Chemoprevention through the consumption of 
natural dietary compounds such as lycopene, resveratrol, 
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genistein may reduce both morbidity and mortality from 
cancer by affecting various signalling pathways suggesting the 
novel cancer preventive strategy [6]. Phytic acid is a complex 
carbohydrate that is a naturally occurring compound found in 
grains, cereals, nuts, and foods that are high in fiber content. 
Some study demonstrated the antitumor effect of phytic acid 
[7]. In a continuing effort to evaluate safer and more effective 
forms of therapy, we investigated the molecular effect of 
phytic acid. 
Epigenetics encompasses the wide range of heritable changes 
in gene expression that do not result from an alteration in the 
DNA sequence itself. DNA methylation, the reversible post-
translational modification define the epigenetic landscape of a 
cell [8]. In cancer cells, increased de novo methylation 
(hypermethylation) of many promoters of tumor suppressors 
genes have been reported [9]. Genes can be transcriptionally 
silenced when their promoter region(s) CpG islands are 
hypermethylated [9]. The p21 protein has been suggested to 
mediate p53-induced growth arrest triggered by DNA damage 
[10]. The presence of hypermethylation of the p21 gene was 
associated with many cases of acute lymphoblastic leukemia 
and was also associated with unfavourable clinical outcome 
[11]. DAPK1 has been shown to suppress the metastatic 
ability of carcinoma cells [12]. Its expression has been shown 
to be absent or decreased in various cancers and cancer cell 
lines [13]. DAPK1 has been reported to be suppressed by 
promoter methylation in malignant tissue but its methylation 
was not found significant in benign tumors or at early stages 
[13]. COX-2 plays central roles in the inflammation associated 
cancer development and act as interface between inflammation 
and cancer. Up-regulated expression of COX-2 is found in 
multiple human cancers including colon, breast, prostate and 
skin [14-16]. In the mouse skin model, COX-2 is 
constitutively overexpressed papillomas and carcinomas [17]. 
In this study we have shown the chemopreventive efficacy of 
phytic acid against DMBA/TPA induced skin tumorigenesis  
via modulation expression of p21, DAPK1 or COX-2 and 
epigenetic status of p21 and DAPK1.  4 weeks end point was 
selected to know molecular changes before the tumor 
development and 16 weeks end point was to know the 
molecular changes that appeared after the tumor development 
 
Material and method  
 
Animals 
Female Swiss albino mice (4-6 weeks old and 10–12gm body 
weight) were used for the study. All the animals were kept in 
12/12 hour light/dark cycle and were fed pellet diet (consisting 
of protein, 21.53%; fat, 5.24%; crude fiber, 5.3%; 
carbohydrate, 57.59%; and caloric value, 363.64 kcal/100 g 
from M/S Ashirwad Pvt. Ltd., Chandigharh, India) with water 
ad libitum. Study was approved and animals were handled 
according to the norms of institutional animal ethics 
committee.  
 
Chemicals 
Phytic acid, 7,12-dimethylbenz[a]anthracene (DMBA), 
phorbol 12-myristate 13-acetate (TPA), sodium metabisulfite, 
and hydroxy quinone were procured from Sigma Co. (St. 
Louis, MO, USA). Ampli gold Taq DNA polymerase, dNTPs, 
MS-PCR primers were procured from Banglore Genei (India). 
The rest of the chemicals were procured from local 
commercial sources and were of analytical grade.  
 
Animal treatment and chronic animal bioassay 
Mice were shaved on the interscapular region of the back and 
only animals in the resting phase of the hair growth were used 
for treatment. DMBA/TPA induced two stage mouse skin 
tumorigenesis model was used in this study. In brief, single 
topical dose of 50 µg DMBA /0.1ml acetone was applied and 
after one week followed by topical treatment of 5 µg TPA 
/0.1ml acetone twice weekly, for 4 or 16 weeks. 2% Phytic 
acid is given in drinking water ad libitum. Animals were 
divided randomly in 4 groups consisting of 10 animals each. 
All treatments were given topically on the shaved back. 
Groups are divided as follows.Gr.1-Acetone, Gr.2- Phytic 
acid, Gr.3- DMBA+TPA, Gr.4- DMBA + TPA + Phytic acid. 
All the animals were sacrificed at the end of 4 or 16 weeks.  
Skin from the painted area was excised, cleaned, snap frozen 
in liquid nitrogen and stored at - 800C till further use.  
 
DNA isolation and bisulfite modification 
DNA was obtained from frozen whole epidermis by proteinase 
digestion followed by phenol–chloroform–isoamyl alcohol 
extraction and ethanol precipitation as described [18]. DNA 
methylation in the CpG islands of the gene promoters was 
determined by chemical modification of genomic DNA with 
sodium bisulfite and subsequent methylation-specific PCR 
(MSP) as described [19, 20]. In brief, 5 µg of DNA was 
denatured by NaOH and modified by sodium bisulfite. DNA 
samples were then purified using Wizard DNA purification 
resin (Promega Corp., Madison, WI), desulphonated by NaOH 
and neutralized by NH4-acetate. DNA was precipitated by 
ethanol using Salmon testis DNA (Sigma Co.) as carrier and 
dissolved in 20 µl of water. 
 
Methylation specific PCR (MS-PCR) 
Methylation of CpGs in p21, DAPK1 and COX-2 gene 
promoter was studied by MS-PCR as reported earlier [21, 22]. 
Modified DNA, thus, obtained was used for hot start PCR 
(Ampli Taq DNA polymerase) with specific primers for 
methylation and unmethylation sequences (Table.1). The 
PCRs were performed with 50 ng bisulfite-modified genomic 
DNA template in 20 µl reaction mixture containing 1 X PCR 
buffer, 0.2 mM dNTP, 1.5 mM MgCl2, 10 pmol each of 
forward and reverse primer, and 1 U Ampligold Taq DNA 
polymerase. The mixture was subjected to denaturation at 
95◦C for 10 min followed by 35 cycles (95◦C for 50 s, 55◦C 
for 60 s, and 72◦C for 60 s) and a final extension at 72◦C for 7 
min in a My-Cycler Thermal cycler from Bio-Rad. PCR 
products were electrophoresed in a 1.5% agarose gel and 
visualized using ethidium bromide. A methylation vs 
unmethylation band intensity ratio was compared among the 
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groups. Quantification was done using Gene Tool Syne gene software. 
Table 1 : Primer sequences and PCR product sizes for MS-PCR 
 
 
Western Blotting 
Skin epidermal tissue lysate (10%) was prepared in lysis 
buffer (pH 7.6) containing 20 mM Tris, sucrose (250 mM),  
MgCl2 (2mM), EDTA (2mM), EGTA (0.5mM), DTT (1mM), 
Na3VO4  (0.03mM), PMSF (2mM) and  protease inhibitor 
cocktail (Sigma). Tissue lysate equivalent to 50 µg proteins 
was resolved on SDS-PAGE using 7.5-12.5% Tris-Glycine 
gel. [23]. The separated proteins were transferred onto 
nitrocellulose membrane (Bio-Rad) followed by blocking with 
5% non fat milk powder (w/v) in Tris buffered saline 
containing 0.1% Tween 20 (TBST) for 1 h at 4ºC. Separate 
membranes were probed with antibodies of p21, DAPK1 and 
COX-2 (Santa Cruz Biotech) for overnight at 4ºC followed by 
washing with TBST. Washed membranes were incubated with 
peroxidase-conjugated appropriate secondary antibody 
(Bangalore Genei, India) for 1 h at 4ºC, and signals were 
visualized by Chemiluminescence HRP detection system from 
Millipore on Versa Doc (Bio-Rad). Membranes were stripped 
and reprobed with β-actin antibody (Sigma Co). 
Quantification was done using Gene Tool Syne gene software. 
 
Statistical analysis 
All the data were subjected to statistical analysis. Mean values 
and ± SE of all the groups were calculated. One way ANOVA 
following Student-Newman-Keuls tests for post hoc analyses 
was employed to assess the statistical significance of the 
difference between different treatment groups. Significance 
was determined in terms of ‘p’ values. A ‘p’ value of <0.05 
was considered to be statistically significant. 
 
Results 
In order to evaluate the molecular basis of anti tumor effects 
of phytic acid, we studied the status of p21, DAPK1 and 
COX-2 expression at protein level before (at 4weeks) and after 
the appearance of tumors (at 16 weeks). We also tried to 
evaluate the promoter methylation status of these genes. 
Deregulation of p21, DAPK1 and COX-2 expression after 
DMBA/TPA application and its prevention by phytic acid 
DNA damage and deregulated cell cycle are the critical early 
changes and preceded tumor development. Since we aimed to 
evaluate the molecular events altered even before the onset of 
the tumor and progresses with time, we assessed the status of 
the representative genes, p21, DAPK1, and COX-2. 
Expression of p21, DAPK1, and COX-2 remained unchanged 
in mice exposed to only acetone or phytic acid at any end 
point of study. But at the end of 4 weeks, in mice exposed to 
DMBA followed by TPA application, p21 and DAPK1 
expression were downregulated by 25% and 10% respectively 
in comparison to acetone treated mice. This downregulation 
was prevented by phytic acid and reduced to 2% and 1% 
respectively in comparison to acetone treated mice. Whereas 
at the end of 4 weeks, in mice exposed to DMBA followed by 
TPA application, COX-2 expression was upregulated by 61% 
in comparison to acetone treated mice. This downregulation 
was prevented by phytic acid and reduced to 1%  in 
comparison to acetone treated mice. At the end of 16 weeks, 
DMBA treated followed by TPA exposed mice showed 
downregulation of p21 and DAPK1 expression by 44% and 
35% respectively in comparison to acetone treated mice. This 
downregulation was prevented by phytic acid and reduced to 
1% and 7% respectively in comparison to acetone treated 
mice. Whereas at the end of 16 weeks, in mice exposed to 
DMBA followed by TPA application, COX-2 expression was 
upregulated by 85% in comparison to acetone treated mice. 
This upregulation was prevented by phytic acid and reduced to 
31% in comparison to acetone treated mice (Fig. 1). 
 
So downregulation of p21, DAPK1 and upregulation of COX-
2 expression appeared even before tumor develop and get 
more with the time during DMBA/TPA induced skin 
tumorigenesis and chemopreventive agent phytic acid tried to 
recover these alterations (Fig.1). 
 
 
Gene Primer Sequence Product 
size 
Annealing 
temp.(C0) 
p21 Methylated  F 5’-GTTAGCGAGTTTTCGGGATC-3’ 
R 5’-CTCGACTACTACAATTAACGTCGAA-3’ 
111 
 
550C 
p21 
Unmethylated 
F 5’GGTTAGTGAGTTTTTGGGATTG-3’ 
R 5’-CTCAACTACTACAATTAACATCAAA-3’ 
112 550C 
DAPK1 
Methylated 
F 5’-TGTATGAGGGGTTCGTAGTAGC-3’ 
R 5’-GATATCGTAATAATCGTCCACGTT-3’ 
136 550C 
DAPK1 
Unmethylated 
 F 5’-TGTATGAGGGGTTTGTAGTAGTGA-3’ 
 R 5’-CAATATCATAATAATCATCCACATT-3’ 
140 550C 
COX-2 
Methylated 
F 5'-TTTGTCGTTGCGGTTTTTGC-3' 
R 5'-AAAACGAACTCCACGTAACG-3' 
118 550C 
COX-2 
Unmethylated 
F 5'-AAAGTTTGTTGTTGTGGTTTTTGT-3' 
R 5'-CTATAAAACAAACTCCACATAACA-3' 
126 550C 
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Fig.1: Downregulation of p21, DAPK1 and upregulation of COX
exposure and its prevention by phytic acid
quantitative analysis of their expression is shown in II, III and IV. Bars represent the standard error.* p<0.05, ** p<0.01, 
p<0.001 in comparison to acetone treated group.
 
Promoter CpG Methylation of p21, DAPK1 and COX
after DMBA/TPA application and its prevention by phytic 
acid 
CpG methylation in the gene promoter is involved in the 
transcriptional silencing of the gene and has been implicated 
in cancers. Having shown the status of the expression of p21, 
DAPK1, and COX-2 at the protein level, further we tried to 
assess promoter CpG methylation status of these genes. 
Promoter CpG methylation of p21, DAPK1, and COX
not observed in mice exposed to only acetone or phytic acid at 
any end point of study. At the end of 4 weeks, 
treatment followed by TPA application resulted into the 
promoter CpG hypermethylation of   p21 and DAPK1
and 26% respectively in comparison to acetone treated mice. 
 et al. / Indian J. Pharm. Biol. Res., 2014; 2(4):61-67 
-2 protein expression in response to DMBA followed by TPA 
. Qualitative analysis of their expression is shown at protein level in I and 
 
-2 
-2 was 
DMBA 
 by 24% 
This hypermethylation was prevented by phytic acid and 
reduced to 1% and 2% respectively in comparison to acetone 
treated mice. Whereas at the end of 16 weeks, DMBA treated 
followed by TPA exposed mice showed increased promoter 
CpG methylation of  of   
respectively in comparison to acetone treated mice. This 
downregulation was prevented by phytic acid and reduced to 
9% and 15% respectively in comparison to acetone treated 
mice. Whereas Promoter CpG methylation of COX
observed in mice exposed to DMBA followed by TPA 
expression both at the end of 4 and 16 weeks end point. Thus 
phytic acid administration tried to reduce the 
hypermethylation of promoter CpG of these genes very 
effectively (Fig.2). 
64 
*** 
p21 and DAPK1 by 96% and 58% 
-2 was not 
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Fig.2: Promoter CpG methylation status of 
prevention by phytic acid. Analysis of their promoter CpG methylation of are shown by MSPCR blots (I) and histograms for 
quantitation based on the ratio of methylated vs unmethylated bands
primer pairs. Lane M = Amplification using methylated primer pairs.
*** p<0.001 in comparison to acetone treated group.
 
Discussion 
Cancer is the leading cause of death worldwide. Although, 
enormous progress made for the diagnosis and treatment of 
various types of cancer, still we do not have the single magic 
drug that can completely and selectively destroy cancerous 
cells. So there is a need to develop or identify the potent 
 et al. / Indian J. Pharm. Biol. Res., 2014; 2(4):61-67 
p21, DAPK1 and COX-2 in response to DMBA followed by TPA exposure and its 
 (II, III, IV). Lane U=Amplification using unmethylated 
 Bars represent the standard error.* p<0.05, ** p<0.01, 
 
chemopreventive agent to overcome the poor clin
of the current treatment avenues. P
potential that has been shown to skin tumor model [7]. But its 
molecular mechanism is not well understood. 
suggested the chemopreventive efficacy of phytic acid against 
DMBA/TPA induced skin tumorigenesis via prevention of 
65 
 
 
ical outcome 
hytic acid posses anticancer 
Here we 
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deregulated expression of p21, DAPK1, COX-2 and promoter 
CpG hypermethylation of p21 and DAPK1. 
 
Aberrant DNA methylation has been found in p21 genes, 
leading to their down-regulation in tumors as in case of tumor 
suppressor genes [24]. We also observed 24% more promoter 
CpG methylation of p21 than control at the end of 4 weeks of 
DMBA / TPA exposure. This suggests the early involvement 
of promoter CpG methylation even before the onset of tumors. 
In later end point (16 weeks), promoter CpG methylation of 
p21 was increased with time. Increased promoter CpG 
methylation at 16 weeks end point was well correlated with 
the p21 down regulation and suggested its relevance in the 
development of tumors from beginning of tumorigenesis. 
In several malignant cell lines, studies have shown that 
expression of DAPK1 is decreased or absent [12]. 
Additionally, decreased expression of this gene imparts 
resistance to interferon-induced apoptosis in cells, and a link 
between the loss of DAPK1 expression and cellular apoptosis 
has been shown to facilitate metastasis, at least in one 
experimental system [25]. Promoter methylation of DAPK1 
gene has been observed in multiple tumor types and may 
increase cellular resistance to programmed cell death [26]. We 
also observed the promoter CpG hypermethylation in DAPK1 
genes after DMBA / TPA exposure from 4 weeks to at the 
time of well defined tumors 16 weeks end point in time 
dependent manner. Moreover, available report suggests 
frequent targeting of the DAPK1 promoter methylation by 
aberrant DNA methyltransferases [27].  
We did not observe promoter CpG hypermethylation in the 
mut p53 and COX-2 gene as it is not frequently regulated via 
promoter CpG methylation. Moreover, available reports 
suggest COX-2 promoter CpG methylation is not a frequently 
occurring phenomenon in cancer [28]. At the protein level, we 
observed over expression of COX-2 after DMBA / TPA 
exposure in time dependent manner. That means level of 
COX-2 increased with time from 4 to 16 weeks of DMBA / 
TPA exposure. More over expression of COX-2 could be the 
reason of skin papilloma appearance in later end point of study 
i.e. 16 weeks. The continued over expression of COX-2 [29], 
is in agreement with the  earlier reports that suggests COX-2 
itself has been shown to be upregulated in various tumors and 
shown to be involved in tumor development [30].  
Upregulation of COX-2 at all the time points in time 
dependent manner could be for its involvement in neoplastic 
transformation and establishment of tumors by altering the 
inflammatory and related processes. Hence, deregulation in 
inflammatory pathways corresponded to the altered epigenetic 
scenario after DMBA/TPA exposure.  
 
We have provided the evidences about the status and the 
involvement of epigenetic and associated events during the 
course of the development of tumors from start to finish. 
Chemopreventive interventions by compound with any 
molecular change are likely to give an insight for targeted 
cancer therapies and prevention [7]. Phytic acid is a naturally 
occurring compound, exhibiting tumor suppressing effect 
through its anti-angiogenic, anti-oxidant and anti 
inflammatory properties [7]. The analysis of the effects of IP6 
on the DMBA/TPA caused molecular modulations suggested 
the possible mechanisms of chemoprevention by these 
compounds. IP6 protected the DMBA/TPA induced  
deregulation of p21, DAPK1 and COX-2 at all the time. 
Prevention was more pronounced at the later end points at 16 
weeks due to higher degree of molecular alterations leading to 
the development of the tumor. 
Phytic acid also protected the p21 and DAPK1 gene promoter 
CpG hypermethylation caused by DMBA / TPA exposure thus 
ultimately restored the expression of p21 and DAPK1. In 
addition to this phytic acid also prevented the DMBA / TPA 
induced over expression of COX-2. its downstream effect on 
the methylation as well suggesting its chemopreventive action 
through the modulation of CpG methylation. 
In summary, our study identified that p21 and DAPK1 
promoter get methylated in DMBA with TPA exposed groups, 
which downregulate the protein expression of these genes and 
contributes in development of skin tumors. On the other hand 
DMBA / TPA exposure caused overexpression of COX-2 in 
time dependent manner. Phytic acid inhibits these 
DMBA/TPA induced molecular changes with restoration of 
p21 and DAPK1 expression in addition to dowregulation 
COX-2 expression. So use of natural compounds can provide 
an effective mean of cancer control. 
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